Home » Topics » BioWorld Science

BioWorld Science
RSS

Beta Pharma begins phase I/II study of BPI-1178 in advanced solid tumors and breast cancer

July 13, 2020

Australia's TGA grants provisional approval to remdesivir

July 13, 2020

Alzumab approved in India for emergency use to treat CRS in patients with COVID-19-related ARDS

July 13, 2020

Oragenics advances TerraCoV2, ends development of AG-013 for oral mucositis

July 13, 2020

BRAF inhibitor ABM-1310 displays potent efficacy in xenograft cancer models

July 13, 2020

Celldex Therapeutics starts enrollment in phase I study of CDX-527

July 13, 2020

Enrollment ongoing in phase I study of KBL-693

July 13, 2020

NBE-Therapeutics initiates phase I/II study of NBE-002

July 13, 2020

Aligos Therapeutics presents preclinical data on ALG-031048

July 13, 2020

First-in-human study of INV-1120

July 13, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...